Atlas Trials

Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis

Clinical trial NCT00864318 · COMPLETED

Trial details

NCT number
NCT00864318
Sponsor
Institut Claudius Regaud
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Germ Cell Tumors
Start date
2009-03-13
Primary completion
2020-10-05
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.